Neuroscientists uncover a brand new drug candidate for treating epilepsy

Temporal lobe epilepsy (TLE) is without doubt one of the most typical forms of epilepsy worldwide. Though symptomatic medicines can be found, one-third of TLE sufferers stay unresponsive to present remedy, so new drug targets are critically wanted. Neuroscientist have not too long ago recognized and developed a brand new drug candidate that has potential for successfully treating TLE by suppressing neuroinflammation.